Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR-30.8%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-30.8%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 3.67% |
| 2023 | 52.20% |
| 2022 | -173.04% |
| 2021 | -48.35% |
| 2020 | 80.20% |
| 2019 | 23.07% |
| 2018 | -661.61% |
| 2017 | 92.19% |
| 2016 | -96.15% |
| 2015 | -830.30% |